Cargando…
Novel Treatment for Graft-versus-Host Disease
Allogeneic hematopoietic cell transplantation is a curative therapy for a variety of hematological diseases, but its success is hampered by acute and chronic graft-versus-host disease (GvHD). In the last five years, multiple novel therapeutic approaches for GvHD have entered the arena. The National...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847314/ https://www.ncbi.nlm.nih.gov/pubmed/36714067 http://dx.doi.org/10.31547/bct-2021-022 |